drugset / Trial / NCT00570245

Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation

NCT00570245

Phase 2 Completed 49 enrolled Mallinckrodt
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of inhaled nitric oxide in prevention of lung graft dysfunction due to ischemia-reperfusion

Timeline

Start
2005-04
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitric Oxide Other / unclassified 10 ppm Inhaled

Indications

No indication recorded.